Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment

2022Cancer InformaticsJournalOpen access

10.1177/11769351221127862 Full text13 citations

Authors

5 authors across 2 institutions in 1 country.

Precious Ayorinde AkinnusiFirst authorCorresponding
- Adekunle Ajasin University (NG)
as printed: Precious A Akinnusi
Samuel Olawale Olubode
- Adekunle Ajasin University (NG)
as printed: Samuel O Olubode
Ayomide Oluwadarasimi Adebesin
- Covenant University (NG)
as printed: Ayomide O Adebesin
Toluwani A. Nana
- Covenant University (NG)
as printed: Toluwani A Nana
Sidiqat A ShodehindeSenior author
- Adekunle Ajasin University (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Computational Drug Discovery Methodslevel 3 · 0.99
Phytochemicals and Antioxidant Activitieslevel 3 · 0.98
Advanced Breast Cancer Therapieslevel 3 · 0.98

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2022 · Cancer Informatics · 13 citations
https://openalex.org/W4304116810

Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment · Sankore